 | • レポートコード：MRC2102QY4489 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のドキソルビシン市場について種類別（凍結乾燥粉末、ドキソルビシン注射）、用途別（臨床抗がん剤、科学実験）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ドキソルビシン市場の概要 ・世界の主要地域別ドキソルビシン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のドキソルビシン市場規模2015-2026：種類別（凍結乾燥粉末、ドキソルビシン注射） ・世界のドキソルビシン市場規模2015-2026：用途別（臨床抗がん剤、科学実験） ・ドキソルビシンの米国市場規模2015-2020 ・ドキソルビシンのヨーロッパ市場規模2015-2020 ・ドキソルビシンの中国市場規模2015-2020 ・ドキソルビシンの日本市場規模2015-2020 ・ドキソルビシンの東南アジア市場規模2015-2020 ・ドキソルビシンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・ドキソルビシンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ドキソルビシンの市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Doxorubicin Market
The global Doxorubicin market size is projected to reach US$ 1081.6 million by 2026, from US$ 870.5 million in 2020, at a CAGR of 3.7% during 2021-2026.
Global Doxorubicin Scope and Market Size
The global Doxorubicin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Doxorubicin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Doxorubicin market is segmented into
Lyophilized Powder
Doxorubicin Injection
Segment by Application, the Doxorubicin market is segmented into
Clinical aiticancer drug
Scientific experiments
The Doxorubicin market is analysed and market size information is provided by regions (countries). Segment by Application, the Doxorubicin market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Doxorubicin Market Share Analysis
Doxorubicin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Doxorubicin business, the date to enter into the Doxorubicin market, Doxorubicin product introduction, recent developments, etc.
The major vendors covered:
Sun Pharmaceuticals
Pfizer
Cipla
Meiji Holdings
Teva
1 Doxorubicin Market Overview
1.1 Doxorubicin Product Scope
1.2 Doxorubicin Segment by Type
1.2.1 Global Doxorubicin Sales by Type (2020-2026)
1.2.2 Lyophilized Powder
1.2.3 Doxorubicin Injection
1.3 Doxorubicin Segment by Application
1.3.1 Global Doxorubicin Sales Comparison by Application (2020-2026)
1.3.2 Clinical aiticancer drug
1.3.3 Scientific experiments
1.4 Doxorubicin Market Estimates and Forecasts (2015-2026)
1.4.1 Global Doxorubicin Sales Growth Rate (2015-2026)
1.4.2 Global Doxorubicin Revenue and Growth Rate (2015-2026)
1.4.3 Global Doxorubicin Price Trends (2015-2026)
2 Doxorubicin Estimate and Forecast by Region
2.1 Global Doxorubicin Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Doxorubicin Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Doxorubicin Sales Market Share by Region (2015-2020)
2.2.2 Global Doxorubicin Revenue Market Share by Region (2015-2020)
2.3 Global Doxorubicin Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Doxorubicin Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Doxorubicin Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Doxorubicin Estimates and Projections (2015-2026)
2.4.2 Europe Doxorubicin Estimates and Projections (2015-2026)
2.4.3 China Doxorubicin Estimates and Projections (2015-2026)
2.4.4 Japan Doxorubicin Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Doxorubicin Estimates and Projections (2015-2026)
2.4.6 India Doxorubicin Estimates and Projections (2015-2026)
3 Global Doxorubicin Competition Landscape by Players
3.1 Global Top Doxorubicin Players by Sales (2015-2020)
3.2 Global Top Doxorubicin Players by Revenue (2015-2020)
3.3 Global Doxorubicin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Doxorubicin as of 2019)
3.4 Global Doxorubicin Average Price by Company (2015-2020)
3.5 Manufacturers Doxorubicin Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Doxorubicin Players (Opinion Leaders)
4 Global Doxorubicin Market Size by Type
4.1 Global Doxorubicin Historic Market Review by Type (2015-2020)
4.1.1 Global Doxorubicin Sales Market Share by Type (2015-2020)
4.1.2 Global Doxorubicin Revenue Market Share by Type (2015-2020)
4.1.3 Global Doxorubicin Price by Type (2015-2020)
4.2 Global Doxorubicin Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Doxorubicin Sales Forecast by Type (2021-2026)
4.2.2 Global Doxorubicin Revenue Forecast by Type (2021-2026)
4.2.3 Global Doxorubicin Price Forecast by Type (2021-2026)
5 Global Doxorubicin Market Size by Application
5.1 Global Doxorubicin Historic Market Review by Application (2015-2020)
5.1.1 Global Doxorubicin Sales Market Share by Application (2015-2020)
5.1.2 Global Doxorubicin Revenue Market Share by Application (2015-2020)
5.1.3 Global Doxorubicin Price by Application (2015-2020)
5.2 Global Doxorubicin Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Doxorubicin Sales Forecast by Application (2021-2026)
5.2.2 Global Doxorubicin Revenue Forecast by Application (2021-2026)
5.2.3 Global Doxorubicin Price Forecast by Application (2021-2026)
6 United States Doxorubicin Market Facts & Figures
6.1 United States Doxorubicin Sales Market Share by Company (2015-2020)
6.2 United States Doxorubicin Sales Market Share by Type (2015-2020)
6.3 United States Doxorubicin Sales Market Share by Application (2015-2020)
7 Europe Doxorubicin Market Facts & Figures
7.1 Europe Doxorubicin Sales Market Share by Company (2015-2020)
7.2 Europe Doxorubicin Sales Market Share by Type (2015-2020)
7.3 Europe Doxorubicin Sales Market Share by Application (2015-2020)
8 China Doxorubicin Market Facts & Figures
8.1 China Doxorubicin Sales Market Share by Company (2015-2020)
8.2 China Doxorubicin Sales Market Share by Type (2015-2020)
8.3 China Doxorubicin Sales Market Share by Application (2015-2020)
9 Japan Doxorubicin Market Facts & Figures
9.1 Japan Doxorubicin Sales Market Share by Company (3015-3030)
9.2 Japan Doxorubicin Sales Market Share by Type (2015-2020)
9.3 Japan Doxorubicin Sales Market Share by Application (2015-2020)
10 Southeast Asia Doxorubicin Market Facts & Figures
10.1 Southeast Asia Doxorubicin Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Doxorubicin Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Doxorubicin Sales Market Share by Application (2015-2020)
11 India Doxorubicin Market Facts & Figures
11.1 India Doxorubicin Sales Market Share by Company (2015-2020)
11.2 India Doxorubicin Sales Market Share by Type (2015-2020)
11.3 India Doxorubicin Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Doxorubicin Business
12.1 Sun Pharmaceuticals
12.1.1 Sun Pharmaceuticals Corporation Information
12.1.2 Sun Pharmaceuticals Business Overview
12.1.3 Sun Pharmaceuticals Doxorubicin Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Sun Pharmaceuticals Doxorubicin Products Offered
12.1.5 Sun Pharmaceuticals Recent Development
12.2 Pfizer
12.2.1 Pfizer Corporation Information
12.2.2 Pfizer Business Overview
12.2.3 Pfizer Doxorubicin Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Pfizer Doxorubicin Products Offered
12.2.5 Pfizer Recent Development
12.3 Cipla
12.3.1 Cipla Corporation Information
12.3.2 Cipla Business Overview
12.3.3 Cipla Doxorubicin Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Cipla Doxorubicin Products Offered
12.3.5 Cipla Recent Development
12.4 Meiji Holdings
12.4.1 Meiji Holdings Corporation Information
12.4.2 Meiji Holdings Business Overview
12.4.3 Meiji Holdings Doxorubicin Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Meiji Holdings Doxorubicin Products Offered
12.4.5 Meiji Holdings Recent Development
12.5 Teva
12.5.1 Teva Corporation Information
12.5.2 Teva Business Overview
12.5.3 Teva Doxorubicin Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Teva Doxorubicin Products Offered
12.5.5 Teva Recent Development
…
13 Doxorubicin Manufacturing Cost Analysis
13.1 Doxorubicin Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Doxorubicin
13.4 Doxorubicin Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Doxorubicin Distributors List
14.3 Doxorubicin Customers
15 Market Dynamics
15.1 Doxorubicin Market Trends
15.2 Doxorubicin Opportunities and Drivers
15.3 Doxorubicin Market Challenges
15.4 Doxorubicin Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Doxorubicin Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Doxorubicin Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Doxorubicin Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Doxorubicin Sales (K Units) by Region (2015-2020)
Table 5. Global Doxorubicin Sales Market Share by Region (2015-2020)
Table 6. Global Doxorubicin Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Doxorubicin Revenue Share by Region (2015-2020)
Table 8. Global Doxorubicin Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Doxorubicin Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Doxorubicin Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Doxorubicin Revenue Share Forecast by Region (2021-2026)
Table 12. Global Doxorubicin (K Units) of Key Companies (2015-2020)
Table 13. Global Doxorubicin Sales Share by Company (2015-2020)
Table 14. Global Doxorubicin Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Doxorubicin Revenue Share by Company (2015-2020)
Table 16. Global Doxorubicin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Doxorubicin as of 2019)
Table 17. Global Doxorubicin Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Doxorubicin Manufacturing Sites and Area Served
Table 19. Manufacturers Doxorubicin Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Doxorubicin Players
Table 22. Global Doxorubicin Sales (K Units) by Type (2015-2020)
Table 23. Global Doxorubicin Sales Share by Type (2015-2020)
Table 24. Global Doxorubicin Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Doxorubicin Price (K Units) by Type (2015-2020)
Table 26. Global Doxorubicin Sales Share by Type (2021-2026)
Table 27. Global Doxorubicin Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Doxorubicin Revenue Share by Type (2021-2026)
Table 29. Global Doxorubicin Price (K Units) by Type (2021-2026)
Table 30. Global Doxorubicin Sales (K Units) by Application (2015-2020)
Table 31. Global Doxorubicin Sales Share by Application (2015-2020)
Table 32. Global Doxorubicin Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Doxorubicin Price (K Units) by Application (2015-2020)
Table 34. Global Doxorubicin Sales (K Units) by Application (2021-2026)
Table 35. Global Doxorubicin Sales Share by Application (2021-2026)
Table 36. Global Doxorubicin Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Doxorubicin Revenue Share by Application (2021-2026)
Table 38. Global Doxorubicin Price (K Units) by Application (2021-2026)
Table 39. United States Doxorubicin Sales (K Units) by Company (2015-2020)
Table 40. United States Doxorubicin Sales Market Share by Company (2015-2020)
Table 41. United States Doxorubicin Sales (K Units) by Type (2015-2020)
Table 42. United States Doxorubicin Sales Market Share by Type (2015-2020)
Table 43. United States Doxorubicin Sales (K Units) by Application (2015-2020)
Table 44. United States Doxorubicin Sales Market Share by Application (2015-2020)
Table 45. Europe Doxorubicin Sales (K Units) by Company (2015-2020)
Table 46. Europe Doxorubicin Sales Market Share by Company (2015-2020)
Table 47. Europe Doxorubicin Sales (K Units) by Type (2015-2020)
Table 48. Europe Doxorubicin Sales Market Share by Type (2015-2020)
Table 49. Europe Doxorubicin Sales (K Units) by Application (2015-2020)
Table 50. Europe Doxorubicin Sales Market Share by Type (2015-2020)
Table 51. China Doxorubicin Sales (K Units) by Company (2015-2020)
Table 52. China Doxorubicin Sales Market Share by Company (2015-2020)
Table 53. China Doxorubicin Sales (K Units) by Type (2015-2020)
Table 54. China Doxorubicin Sales Market Share by Type (2015-2020)
Table 55. China Doxorubicin Sales (K Units) by Application (2015-2020)
Table 56. China Doxorubicin Sales Market Share by Application (2015-2020)
Table 57. Japan Doxorubicin Sales (K Units) by Company (2015-2020)
Table 58. Japan Doxorubicin Sales Market Share by Company (2015-2020)
Table 59. Japan Doxorubicin Sales (K Units) by Type (2015-2020)
Table 60. Japan Doxorubicin Sales Market Share by Type (2015-2020)
Table 61. Japan Doxorubicin Sales (K Units) by Application (2015-2020)
Table 62. Japan Doxorubicin Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Doxorubicin Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Doxorubicin Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Doxorubicin Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Doxorubicin Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Doxorubicin Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Doxorubicin Sales Market Share by Application (2015-2020)
Table 69. India Doxorubicin Sales (K Units) by Company (2015-2020)
Table 70. India Doxorubicin Sales Market Share by Company (2015-2020)
Table 71. India Doxorubicin Sales (K Units) by Type (2015-2020)
Table 72. India Doxorubicin Sales Market Share by Type (2015-2020)
Table 73. India Doxorubicin Sales (K Units) by Application (2015-2020)
Table 74. India Doxorubicin Sales Market Share by Application (2015-2020)
Table 75. Sun Pharmaceuticals Corporation Information
Table 76. Sun Pharmaceuticals Description and Business Overview
Table 77. Sun Pharmaceuticals Doxorubicin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Sun Pharmaceuticals Doxorubicin Product
Table 79. Sun Pharmaceuticals Recent Development
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Doxorubicin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Pfizer Doxorubicin Product
Table 84. Pfizer Recent Development
Table 85. Cipla Corporation Information
Table 86. Cipla Description and Business Overview
Table 87. Cipla Doxorubicin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Cipla Doxorubicin Product
Table 89. Cipla Recent Development
Table 90. Meiji Holdings Corporation Information
Table 91. Meiji Holdings Description and Business Overview
Table 92. Meiji Holdings Doxorubicin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Meiji Holdings Doxorubicin Product
Table 94. Meiji Holdings Recent Development
Table 95. Teva Corporation Information
Table 96. Teva Description and Business Overview
Table 97. Teva Doxorubicin Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Teva Doxorubicin Product
Table 99. Teva Recent Development
Table 100. Production Base and Market Concentration Rate of Raw Material
Table 101. Key Suppliers of Raw Materials
Table 102. Doxorubicin Distributors List
Table 103. Doxorubicin Customers List
Table 104. Doxorubicin Market Key Trends
Table 105. Doxorubicin Key Opportunities and Drivers
Table 106. Doxorubicin Market Challenges
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Doxorubicin Product Picture
Figure 2. Global Doxorubicin Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Doxorubicin Market Share by Application in 2020 & 2026
Figure 6. Clinical aiticancer drug Examples
Figure 7. Scientific experiments Examples
Figure 8. Global Doxorubicin Sales (K Units) Growth Rate (2015-2026)
Figure 9. Global Doxorubicin Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Doxorubicin Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 11. Global Doxorubicin Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Doxorubicin Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Doxorubicin Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Doxorubicin Sales (K Units) Growth Rate (2015-2026)
Figure 15. Europe Doxorubicin Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Doxorubicin Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Doxorubicin Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Doxorubicin Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Doxorubicin Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Doxorubicin Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Doxorubicin Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Doxorubicin Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Doxorubicin Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Doxorubicin Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Doxorubicin Players Market Share by Revenue in Doxorubicin 2015 & 2019
Figure 26. Doxorubicin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Doxorubicin Revenue Share by Type (2015-2020)
Figure 28. Global Doxorubicin Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Doxorubicin Revenue Share by Application (2015-2020)
Figure 30. Global Doxorubicin Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Doxorubicin Sales Market Share by Type in 2019
Figure 32. United States Doxorubicin Sales Market Share by Type in 2019
Figure 33. Europe Doxorubicin Sales Market Share by Company in 2019
Figure 34. Europe Doxorubicin Sales Market Share by Type in 2019
Figure 35. Europe Doxorubicin Sales Market Share by Application in 2019
Figure 36. China Doxorubicin Sales Market Share by Company in 2019
Figure 37. China Doxorubicin Sales Market Share by Type in 2019
Figure 38. China Doxorubicin Sales Market Share by Application in 2019
Figure 39. Japan Doxorubicin Sales Market Share by Company in 2019
Figure 40. Japan Doxorubicin Sales Market Share by Type in 2019
Figure 41. Japan Doxorubicin Sales Market Share by Application in 2019
Figure 42. Southeast Asia Doxorubicin Sales Market Share by Company in 2019
Figure 43. Southeast Asia Doxorubicin Sales Market Share by Type in 2019
Figure 44. Southeast Asia Doxorubicin Sales Market Share by Application in 2019
Figure 45. India Doxorubicin Sales Market Share by Company in 2019
Figure 46. India Doxorubicin Sales Market Share by Type in 2019
Figure 47. India Doxorubicin Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Doxorubicin
Figure 50. Manufacturing Process Analysis of Doxorubicin
Figure 51. Doxorubicin Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
リポソーム化ドキソルビシンの世界市場レポート2020 Liposome doxorubicin is a commonly used anthracycline anti-tumor drug, and is one of the first-line drugs for ovarian cancer. Market competition is intense. Johnson & Johnson, Sun Pharmaceutical, CSPC, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end cu…- リポソームドラッグデリバリーの世界市場レポート2020 Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical…
- 腫瘍学注射薬の世界市場レポート2020 Market Analysis and Insights: Global Oncology Injection Drug Market The global Oncology Injection Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Oncology Injection Drug Scope and Market Size The global Oncology In…
- 注射・注入ベースドラッグデリバリーデバイスの世界市場レポート2020 Market Analysis and Insights: Global Injection And Infusion-based Drug Delivery Devices Market The global Injection And Infusion-based Drug Delivery Devices market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Injection And …
- 臨床免疫分析装置の世界市場レポート2020 Clinical Immunoanalyzer detect and quantify specific analytes in blood or in samples of body fluids by utilizing immunoassay methodologies such as immunoprecipitation, particle immunoassays, immunonephelometry, radioimmunoassay, enzyme immunoassay, fluorescent immunoassay, and chemiluminescent immun…